PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 28 filers reported holding PROTEON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $5,000 | -78.3% | 10,000 | 0.0% | 0.00% | – |
| Q4 2018 | $23,000 | +15.0% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $20,000 | -20.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $25,000 | 0.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $25,000 | +31.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $19,000 | -5.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $20,000 | +33.3% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $15,000 | -21.1% | 10,000 | -10.1% | 0.00% | 0.0% |
| Q1 2017 | $19,000 | -9.5% | 11,125 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $21,000 | – | 11,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 315,101 | $482,000 | 15.66% |
| Pharmstandard International S.A. | 1,165,344 | $1,777,000 | 6.16% |
| Abingworth LLP | 2,017,872 | $3,027,000 | 2.41% |
| MPM ASSET MANAGEMENT LLC | 983,381 | $1,505,000 | 0.65% |
| RA Capital Management | 1,337,462 | $2,040,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,224,899 | $1,868,000 | 0.10% |
| Perceptive Advisors | 334,116 | $518,000 | 0.03% |
| WEDBUSH SECURITIES INC | 53,439 | $81,000 | 0.01% |
| Baker Brothers Advisors | 298,591 | $455,000 | 0.00% |
| FINANCIAL COUNSELORS INC | 50,000 | $78,000 | 0.00% |